Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 115

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 115
---
 earned her BSA in accounting and finance at California State University, Long Beach.

Ms.
Kim’s qualifications to serve as our Chief Financial Officer are primarily based on her 35 years of accounting and finance experience
both as a CFO and as a CPA in major global accounting and consultancy firms.

Dr. Joseph M. Palumbo has served as our
Chief Medical Officer (“CMO”) since 2021.
Formerly he served as the CMO at Zynerba Pharmaceuticals from July 2019 to October 2021, responsible for clinical operations, development,
regulatory, and medical affairs. Prior to his time at Zynerba, Dr. Palumbo held senior worldwide governance roles at Mitsubishi Tanabe
Pharma in both the United States and Japan from April 2012 to June 2019, where he led medical science and translational research across
multiple therapeutic areas, and guided successful registrational programs for Radicava® (edaravone) for the treatment of Amyotrophic
Lateral Sclerosis. From April 2003 to March 2012, Dr. Palumbo was Global Head and Franchise Medical Leader for Psychiatry, and the Interim
Head of Global Neuroscience at Johnson & Johnson, where he led the medical teams who achieved successful global registrations for
Risperdal® (risperidone); Concerta® (methylphenidate HCL); and Invega® (paliperidone). He was Head of Psychiatry and Neurology
at Pharmanet for from April 2002 to April 2003. Dr Palumbo previously held industry positions in European Pharma with Sanofi-Synthelabo
from April 1999 to April 2002, Biotech at Cephalon, from April 1997 to April 1998, and from July 1989 to April 2002, he held senior leadership
and hospital administration roles at prestigious academic research institutions including Yale, Cornell, and the University of Pennsylvania.
He holds a Bachelor of Arts at the University of Pennsylvania and received his Doctor of Medicine at the George Washington University
School of Medicine. He was a Biological Sciences Training Program Fellow of the National Institutes of Health and Chief Resident for
the Abraham Ribicoff Clinical Neuroscience Research Unit at Yale University. Dr Palumbo has received Board Certification in Psychiatry
and Addiction Psychiatry.

<div align='center'>60</div>

Dr. Palumbo’s qualifications to serve as
our CMO is based on the decades and depth of experiences in the roles he has